These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 951464)

  • 1. The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine.
    Johnstone EC
    Psychopharmacologia; 1976 Apr; 46(3):289-94. PubMed ID: 951464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J; McLeod MN; Blum MR
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between response to phenelzine and acetylator status in depressed patients.
    Johnstone EC; Marsh W
    Proc R Soc Med; 1973 Sep; 66(9):947-9. PubMed ID: 4616245
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylator phenotype in relation to monoamine oxidase inhibitor antidepressant drug therapy.
    Whitford GM
    Int Pharmacopsychiatry; 1978; 13(2):126-32. PubMed ID: 352977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL; Brand E; Goldman T; Baker M; Wright C; van Kammen D; Gordon E
    J Nerv Ment Dis; 1977 Feb; 164(2):129-34. PubMed ID: 836485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenelzine: acetylator status and clinical response.
    Sanders GL; Rawlins MD
    Br J Clin Pharmacol; 1979 May; 7(5):451-2. PubMed ID: 475942
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT; Mozayani A; Danielson TJ; Baker GB
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylator status and response to phenelzine.
    Tilstone WJ; Johnstone EC
    Lancet; 1978 Nov; 2(8100):1151-2. PubMed ID: 82710
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
    Beckmann H; Murphy DL
    Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of acetylator phenotype on antidepressant effects of phenelzine.
    Paykel ES; West PS; Rowan PR; Parker RR
    Br J Psychiatry; 1982 Sep; 141():243-8. PubMed ID: 6753997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between acetylator status and response to phenelzine.
    Johnstone EC
    Mod Probl Pharmacopsychiatry; 1975; 10():30-7. PubMed ID: 1101047
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of acetylation phenotype to treatment with MAOIs: a review.
    Rose S
    J Clin Psychopharmacol; 1982 Jun; 2(3):161-4. PubMed ID: 7096607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase inhibitors. A review of antidepressant effectiveness.
    Quitkin F; Rifkin A; Klein DF
    Arch Gen Psychiatry; 1979 Jul; 36(7):749-60. PubMed ID: 454092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep and sleep electroencephalogram in depressed patients treated with phenelzine.
    Landolt HP; Raimo EB; Schnierow BJ; Kelsoe JR; Rapaport MH; Gillin JC
    Arch Gen Psychiatry; 2001 Mar; 58(3):268-76. PubMed ID: 11231834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.